Susan M. Lantz

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

NCTR

Also affiliated: United States Food and Drug Administration (2010–2019); Trine University (2020)

14 h-index 27 pubs 1,051 cited

Research Areas

Biomedical Subjects

OverviewAI-generated summary

Susan M. Lantz's research has focused on the study of toxicological properties, particularly concerning the blood-brain barrier and its permeability. Her work has investigated the effects of specific agents on microvessels and endothelial cells, utilizing animal models such as Sprague-Dawley rats. Lantz has contributed to the scientific literature through numerous publications, with a recent focus on retraction notices for prior work. Her scholarship metrics include an h-index of 14, with a total of 27 publications and over 1,000 citations. She has collaborated with several researchers at the National Center for Toxicological Research, including Glenn D. Newport, Qiangen Wu, and Syed F. Ali.

Metrics

h-index: 14
Publications: 27
Citations: 1,051

Selected Publications

Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296] (2025)

Neurotoxicology and Teratology DOI OpenAlex
Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78] (2024)

Neuroscience Letters DOI OpenAlex
Dr. Daniel Acosta and In Vitro toxicology at the U.S. Food and Drug Administration's National Center for Toxicological Research (2019)

Toxicology in Vitro 4 citations DOI OpenAlex
Cytotoxicity profile of pristine graphene on brain microvascular endothelial cells (2019)

Journal of Applied Toxicology 12 citations DOI OpenAlex
Characterization of uniaxial high-speed stretch as an in vitro model of mild traumatic brain injury on the blood-brain barrier (2018)

Neuroscience Letters 15 citations DOI OpenAlex
Ontogeny of Second Messenger Systems (2018)

Elsevier eBooks 1 citation DOI OpenAlex
Blood–Brain Barrier: Physiological and Functional Considerations (2018)

Elsevier eBooks 7 citations DOI OpenAlex
Isolation and Culture of Brain Microvascular Endothelial Cells for In Vitro Blood-Brain Barrier Studies (2017)

Methods in molecular biology 28 citations DOI OpenAlex
Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin study (2017)

Experimental Biology and Medicine 22 citations DOI OpenAlex
Characterization of Biaxial Stretch as an In Vitro Model of Traumatic Brain Injury to the Blood-Brain Barrier (2017)

Molecular Neurobiology 21 citations DOI OpenAlex
Monoaminergic toxicity induced by cathinone phthalimide: An in vitro study (2017)

Neuroscience Letters 9 citations DOI OpenAlex
Neurovascular unit components on a chip as a model to study traumatic brain injury (2016)

Toxicology Letters 1 citation DOI OpenAlex
Protein Kinases and Parkinson’s Disease (2016)

International Journal of Molecular Sciences 36 citations DOI OpenAlex
Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells (2016)

Neuroscience Letters 39 citations DOI OpenAlex
In vitro detection of cytotoxicity using FluoroJade-C (2014)

Toxicology in Vitro 14 citations DOI OpenAlex